ProJect Pharmaceutics and TUM-Spin-off ImevaX announce agreement on development of pharmaceutical formulation for IMX101 Read More » December 2, 2013 Introducing formulation and lyophilization process development for cytotoxic and other highly potent drugs Read More » July 30, 2012 Joint Development of a novel lyophilized Dual Chamber Prefillable Syringe System Read More » June 5, 2012 Check your Lyo Cycle! Read More » May 24, 2012 Formulations for clinical trials and beyond Read More » May 9, 2012 ProJect Pharmaceutics introduces Predictive Formulation Analytics for a rational design of optimized biopharmaceutical formulations. Read More » December 14, 2011 EuroBioTechNews: From development to launch Read More » September 8, 2011 Introducing an optimized process management concept from drug development to drug manufacturability: Advaceutics® Read More » August 24, 2011 Transforming proteins into pioneering drugs – ProJect Pharmaceutics started operations Read More » May 26, 2011 Page1 Page2 Page3
ProJect Pharmaceutics and TUM-Spin-off ImevaX announce agreement on development of pharmaceutical formulation for IMX101 Read More » December 2, 2013
Introducing formulation and lyophilization process development for cytotoxic and other highly potent drugs Read More » July 30, 2012
Joint Development of a novel lyophilized Dual Chamber Prefillable Syringe System Read More » June 5, 2012
ProJect Pharmaceutics introduces Predictive Formulation Analytics for a rational design of optimized biopharmaceutical formulations. Read More » December 14, 2011
Introducing an optimized process management concept from drug development to drug manufacturability: Advaceutics® Read More » August 24, 2011
Transforming proteins into pioneering drugs – ProJect Pharmaceutics started operations Read More » May 26, 2011
